Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
LifeMD Inc(LFMD)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for LFMD
10/09/2026: LFMD (1-star) is currently NOT-A-BUY. Pass it for now.
LifeMD Inc is a telehealth company that operates a virtual care platform providing both primary care and specialized treatment programs, such as weight management and men's health. The company has shown strong revenue growth by leveraging a direct-to-consumer model and integrating its own telehealth technology and pharmacy services. Its primary growth opportunity lies in the continued adoption of clinical weight loss programs. However, it faces significant risks from intense competition, high customer acquisition costs, and potential regulatory shifts in remote prescribing. Investors should view this as a high-growth, high-volatility opportunity, monitoring its progress in improving unit economics and expanding its insurance-reimbursed care base.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | LifeMD is a high-growth telehealth company targeting significant market opportunities in weight management and virtual care. |
| Momentum investor | Mixed fit | The stock's performance is highly sensitive to sector-wide sentiment and growth signals; momentum strategies depend on positive catalysts. |
| Value investor | Weak fit | The company is not currently focused on traditional value metrics like P/E ratios due to its ongoing investment phase. |
| Dividend investor | Weak fit | LifeMD does not pay a dividend and is focused on reinvestment. |
| Low-risk investor | Weak fit | The stock exhibits high volatility typical of small-cap health-tech stocks. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock price is subject to significant swings based on industry trends and company-specific growth news. |
| Valuation risk | Medium / high | Market sentiment regarding growth stocks can lead to significant valuation fluctuations. |
| Competition risk (Direct telehealth competition) | High | LifeMD faces aggressive competition from Hims & Hers and other platforms for customer acquisition. |
| Business quality | Medium | While the platform is robust, the company is still building long-term profitability and sustainable moats. |
| Dividend income | Low / none | No dividends are expected in the near future. |
| Execution risk | Medium / high | Successfully scaling clinical operations while managing customer acquisition costs is a primary operational challenge. |
Price Behavior
Downtrend
The stock has experienced a sustained decline in price over recent periods.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit 19.48% | Avg. Invested days 30 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 10/09/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 127.88M USD | Price to earnings Ratio - | 1Y Target Price 8.12 |
Price to earnings Ratio - | 1Y Target Price 8.12 | ||
Volume (30-day avg) 798.4K shares | Beta 1.99 | 52 Weeks Range 2.56 - 6.53 | Updated Date 10/09/2026 |
52 Weeks Range 2.56 - 6.53 | Updated Date 10/09/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.51 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Telehealth and Wellness Subscriptions | Subscription revenue from RexMD, NavaMD, and weight management clinical programs. | The company makes money when people subscribe to their virtual doctor services and receive recurring prescription medication shipments. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Valuation
Trailing PE - | Forward PE 12.85 | Enterprise Value 128.13M | Price to Sales(TTM) 0.67 |
Enterprise Value 128.13M | Price to Sales(TTM) 0.67 | ||
Enterprise Value to Revenue 0.67 | Enterprise Value to EBITDA 36.71 | Shares Outstanding 48.26M | Shares Floating 39.66M |
Shares Outstanding 48.26M | Shares Floating 39.66M | ||
Percent Insiders 15.8 | Percent Institutions 47.73 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.